DH

DH

USD

Definitive Healthcare Corp. Class A Common Stock

$2.710+0.020 (0.743%)

Reaalajas hind

Healthcare
Health Information Services
Ameerika Ühendriigid

Hinnagraafik

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$2.690

Kõrge

$2.730

Madal

$2.647

Maht

0.05M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

292.6M

Tööstusharu

Health Information Services

Riik

United States

Kauplemisstatistika

Keskmine maht

1.10M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $2.15Praegune $2.710Kõrge $7.471

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 27. apr 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

DH (Definitive Healthcare Corp. Class A Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: DH Generate Date: 2025-04-27 22:23:28

Alright, let's break down what's been happening with Definitive Healthcare stock lately and what the data we have might suggest. This company, remember, is all about selling data and software to folks in the healthcare world – think hospitals, drug companies, device makers, and so on. It's a specific niche, and not a giant company by market cap standards (around $292 million).

Recent News Buzz

What's the story from the latest headlines? We've got two main bits of news here.

First, the company announced when they'll be sharing their financial results for the first quarter of 2025. This is pretty standard stuff for a public company; they have to tell everyone how they did. It doesn't tell us how they did, just when we'll find out.

The second piece of news is more interesting. Definitive Healthcare reported giving out some special stock grants as part of hiring a new senior person. Bringing in senior talent is usually seen as a positive step for a company. It suggests they're investing in leadership and potentially looking to boost performance or strategy. So, while the earnings call timing is neutral, the hiring news leans a bit positive.

Checking the Price Action

Now, let's look at what the stock price itself has been doing over the past month or so. Looking at the chart data, things got pretty rough for DH. Towards the end of March, the stock was trading around the $2.90 to $3.00 mark. Then, right at the start of April, it took a significant tumble. It dropped sharply and even hit a 52-week low of $2.15 around April 9th.

Since hitting that low point, the price has managed to bounce back somewhat. It's been trading mostly between $2.40 and $2.70, and it closed recently right at $2.71. So, the big picture over the last month is a sharp decline followed by a modest recovery off the absolute lows.

What about the very near future? The AI prediction model we have suggests the price might stay flat today (0.00% change predicted), but then it sees a couple of slightly positive days ahead, predicting a 1.41% increase the next day and a 2.79% increase the day after that.

Putting It All Together: Outlook & Ideas

So, where does that leave us? We've got a stock that's been hammered but recently bounced off its yearly low. The latest news includes a positive note about hiring, and the AI is forecasting a small upward move in the immediate future. The recommendation data we have also flags DH with a moderately positive score, calling it a potential "Undervalued Gem" and noting positive technical signs like trading volume and a bullish trend indicator (DMI), alongside the positive news sentiment and AI prediction. It does point out fundamental challenges like negative growth and high debt, plus a low P/E ratio which could be seen as cheap or a sign of trouble depending on your view.

Given the bounce from the lows, the slightly positive news, and the AI's short-term forecast, the immediate leaning here seems to be away from further sharp declines, at least for the moment. It might suggest a 'hold' if you're already in, or perhaps looking for potential entry points if you're not.

If someone were considering getting in based on this data, the recommendation system points to potential entry levels around $2.70 to $2.73. The current price is right in that zone ($2.71). This level is also where the stock has been trading recently after its bounce.

For managing risk, the recommendation data offers some ideas. A potential stop-loss level is suggested at $2.45. This is below the recent trading range and well below the current price, giving the stock some room to move but setting a point to cut losses if the recent recovery fails and it heads back towards or below the April lows. On the upside, a potential take-profit level is mentioned at $2.94. This is near where the stock was trading before its big drop in early April and could act as a short-term target if the predicted upward movement materializes.

Remember, this is just an interpretation based on the data provided right now. Market conditions can change fast, and this stock has shown it can be quite volatile.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Investing in stocks involves risk, and you could lose money. Always do your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Seotud uudised

GlobeNewswire

Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast

FRAMINGHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that it will report

Vaata rohkem
Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast
GlobeNewswire

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior

Vaata rohkem
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 28. apr 2025, 09:39

LangevNeutraalneTõusev

63.5% Kindlus

Risk ja kauplemine

Riskitase4/5
Kõrge risk
Sobib
Väärtus
Kauplemisjuhend

Sisenemispunkt

$2.70

Võta kasum

$2.94

Peata kahjum

$2.45

Põhitegurid

PDI 14.1 on MDI 10.4 kohal ADX-iga 12.3, mis viitab tõusutrendile
Praegune hind on tugitasemele ($2.71) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 3.0x keskmisest (13,247), mis viitab äärmiselt tugevale ostusurvele
MACD 0.0019 on signaalijoone 0.0027 all, mis viitab langevale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.